Atrial natriuretic peptide for the prevention of contrast-induced nephropathy: what's old is new but at the right dose and duration of therapy!
作者信息
Chen Horng H
出版信息
J Am Coll Cardiol. 2009 Mar 24;53(12):1047-9. doi: 10.1016/j.jacc.2008.12.020.
Abstract
摘要
相似文献
1
Atrial natriuretic peptide for the prevention of contrast-induced nephropathy: what's old is new but at the right dose and duration of therapy!心房利钠肽用于预防造影剂肾病：旧药新用，但需合适的治疗剂量和疗程！
J Am Coll Cardiol. 2009 Mar 24;53(12):1047-9. doi: 10.1016/j.jacc.2008.12.020.
2
Prevention of contrast nephropathy after cardiac catheterisation.心脏导管插入术后对比剂肾病的预防
Heart. 2001 Apr;85(4):361-2. doi: 10.1136/heart.85.4.361.
3
Prevention of contrast-induced nephropathy with sodium bicarbonate.碳酸氢钠预防对比剂肾病
JAMA. 2004 Sep 22;292(12):1428; author reply 1428-9. doi: 10.1001/jama.292.12.1428-a.
4
Prevention of contrast-induced nephropathy with sodium bicarbonate.用碳酸氢钠预防对比剂肾病
JAMA. 2004 Sep 22;292(12):1428; author reply 1428-9. doi: 10.1001/jama.292.12.1428-b.
5
Contrast nephropathy.对比剂肾病
J Am Soc Nephrol. 2000 Jan;11(1):177-182. doi: 10.1681/ASN.V111177.
6
Prevention of contrast-induced nephropathy in patients undergoing emergent coronary procedures.急诊冠状动脉手术患者中对比剂肾病的预防
Am J Cardiol. 2008 Mar 15;101(6):910. doi: 10.1016/j.amjcard.2007.11.005.
7
Sodium bicarbonate vs sodium chloride in preventing contrast medium-induced nephropathy.
JAMA. 2009 Jan 28;301(4):378; author reply 379-380. doi: 10.1001/jama.2009.18.
8
Sodium bicarbonate vs sodium chloride in preventing contrast medium-induced nephropathy.
JAMA. 2009 Jan 28;301(4):377; author reply 379-380. doi: 10.1001/jama.2009.16.
9
Does N-acetylcysteine prevent contrast-induced nephropathy?N-乙酰半胱氨酸能预防造影剂肾病吗？
Am J Cardiol. 2002 Dec 15;90(12):1424; author reply 1424-5. doi: 10.1016/s0002-9149(02)02747-9.
10
Targeted renal therapy: a potential weapon in the battle against CIN.
J Endovasc Ther. 2009 Feb;16(1):13-4. doi: 10.1583/08-2515C.1.
引用本文的文献
1
Effect of trimetazidine on preventing contrast-induced nephropathy in diabetic patients with renal insufficiency.曲美他嗪对预防肾功能不全糖尿病患者造影剂肾病的作用。
Oncotarget. 2017 Jul 24;8(60):102521-102530. doi: 10.18632/oncotarget.19519. eCollection 2017 Nov 24.
本文引用的文献
1
Renal protective effects and the prevention of contrast-induced nephropathy by atrial natriuretic peptide.心房利钠肽的肾脏保护作用及对造影剂肾病的预防
J Am Coll Cardiol. 2009 Mar 24;53(12):1040-6. doi: 10.1016/j.jacc.2008.10.061.
2
Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy.荟萃分析：预防造影剂肾病药物的有效性
Ann Intern Med. 2008 Feb 19;148(4):284-94. doi: 10.7326/0003-4819-148-4-200802190-00007.
3
Low dose nesiritide and the preservation of renal function in patients with renal dysfunction undergoing cardiopulmonary-bypass surgery: a double-blind placebo-controlled pilot study.低剂量奈西立肽与体外循环手术中肾功能不全患者肾功能的保护：一项双盲安慰剂对照的初步研究。
Circulation. 2007 Sep 11;116(11 Suppl):I134-8. doi: 10.1161/CIRCULATIONAHA.106.697250.
4
Effects of perioperative nesiritide in patients with left ventricular dysfunction undergoing cardiac surgery:the NAPA Trial.围手术期奈西立肽对接受心脏手术的左心室功能不全患者的影响：NAPA试验
J Am Coll Cardiol. 2007 Feb 13;49(6):716-26. doi: 10.1016/j.jacc.2006.10.048. Epub 2006 Dec 11.
5
Nonhypotensive low-dose nesiritide has differential renal effects compared with standard-dose nesiritide in patients with acute decompensated heart failure and renal dysfunction.在急性失代偿性心力衰竭和肾功能不全患者中，与标准剂量奈西立肽相比，非低血压低剂量奈西立肽具有不同的肾脏效应。
J Am Coll Cardiol. 2006 Jun 6;47(11):2334-5. doi: 10.1016/j.jacc.2006.03.013. Epub 2006 May 16.
6
Pathophysiology of contrast medium-induced nephropathy.造影剂诱发肾病的病理生理学
Kidney Int. 2005 Jul;68(1):14-22. doi: 10.1111/j.1523-1755.2005.00377.x.
7
Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure.急性失代偿性心力衰竭患者使用奈西立肽后肾功能恶化的风险。
Circulation. 2005 Mar 29;111(12):1487-91. doi: 10.1161/01.CIR.0000159340.93220.E4. Epub 2005 Mar 21.
8
Nesiritide does not improve renal function in patients with chronic heart failure and worsening serum creatinine.奈西立肽不能改善慢性心力衰竭且血清肌酐恶化患者的肾功能。
Circulation. 2004 Sep 21;110(12):1620-5. doi: 10.1161/01.CIR.0000141829.04031.25. Epub 2004 Aug 30.
9
Recombinant human atrial natriuretic peptide in ischemic acute renal failure: a randomized placebo-controlled trial.重组人心房利钠肽治疗缺血性急性肾衰竭：一项随机安慰剂对照试验
Crit Care Med. 2004 Jun;32(6):1310-5. doi: 10.1097/01.ccm.0000128560.57111.cd.
10
Atrial natriuretic factor in oliguric acute renal failure. Anaritide Acute Renal Failure Study Group.少尿型急性肾衰竭中的心房利钠因子。阿那利肽急性肾衰竭研究组。
Am J Kidney Dis. 2000 Oct;36(4):767-74. doi: 10.1053/ajkd.2000.17659.
Zotero 插件